NTLA - Intellia Therapeutics, Inc.
IEX Last Trade
12.15
-0.025 -0.206%
Share volume: 30,600
Last Updated: Thu 26 Dec 2024 08:30:12 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$12.18
-0.03
-0.21%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-09 | 2024-02-22 | 2024-05-09 | |
| Total revenue | 14.030 M | 13.266 M | 13.573 M | 12.606 M | 13.594 M | 11.992 M | -1.917 M | 28.935 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 14.030 M | 13.266 M | 13.573 M | 12.606 M | 13.594 M | 11.992 M | -1.917 M | 28.935 M | |
| -5.45% | 2.31% | -7.12% | 7.84% | -11.78% | -115.99% | 1,609.39% | |||
| Operating expenses | 112.331 M | 118.796 M | 123.660 M | 124.564 M | 145.928 M | 143.099 M | 137.975 M | 142.938 M | |
| Selling general and admin | 22.132 M | 22.145 M | 23.626 M | 27.448 M | 30.652 M | 29.403 M | 28.994 M | 31.091 M | |
| Research and development | 90.199 M | 96.651 M | 100.034 M | 97.116 M | 115.276 M | 113.696 M | 108.981 M | 111.847 M | |
| Total expenses | 115.583 M | 120.630 M | 126.908 M | 127.612 M | 149.928 M | 146.956 M | 142.703 M | 142.938 M | |
| 4.37% | 5.20% | 0.55% | 17.49% | -1.98% | -2.89% | 0.16% | |||
| Operating income | -101.553 M | -107.364 M | -113.335 M | -115.006 M | -136.334 M | -134.964 M | -144.620 M | -114.003 M | |
| Ebit | -101.553 M | -107.364 M | -113.335 M | -115.006 M | -136.334 M | -134.964 M | -144.620 M | -114.003 M | |
| Pretax income | -100.678 M | -113.229 M | -113.407 M | -103.126 M | -123.681 M | -122.224 M | -132.161 M | -107.436 M | |
| 12.47% | 0.16% | -9.07% | 19.93% | -1.18% | 8.13% | -18.71% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -100.678 M | -113.229 M | -113.407 M | -103.126 M | -123.681 M | -122.224 M | -132.161 M | -107.436 M | |
| -12.47% | -0.16% | 9.07% | -19.93% | 1.18% | -8.13% | 18.71% | |||
| Net income | -100.678 M | -113.229 M | -113.407 M | -103.126 M | -123.681 M | -122.224 M | -132.161 M | -107.436 M | |
| -12.47% | -0.16% | 9.07% | -19.93% | 1.18% | -8.13% | 18.71% |